Literature DB >> 8154932

Bone turnover in non-steroid treated rheumatoid arthritis.

J E Compston1, S Vedi, P I Croucher, N J Garrahan, M M O'Sullivan.   

Abstract

OBJECTIVE: To examine whether changes in cancellous bone turnover and resorption cavity depth contribute to bone loss in patients with non-steroid treated rheumatoid arthritis.
METHODS: Iliac crest biopsies were obtained from 37 patients with non-steroid treated rheumatoid arthritis, 13 male and 24 female, aged 37-71 years. Bone turnover and resorption cavity characteristics were quantitatively assessed using semiautomated computerised techniques.
RESULTS: When compared with age- and sex-matched control values, there was a significant reduction in bone formation rate at tissue level and activation frequency (P < 0.001) in the patient group. The eroded perimeter, mean and maximum eroded depth and cavity area were also significantly reduced (P < 0.01, < 0.005, < 0.01 and < 0.005 respectively).
CONCLUSION: These results demonstrate low bone turnover in non-steroid treated rheumatoid arthritis and indicate that the reduced bone mass in these patients is due mainly to a negative remodelling balance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8154932      PMCID: PMC1005279          DOI: 10.1136/ard.53.3.163

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  32 in total

1.  Bone mineral density in rheumatoid arthritis measured by the gamma transmission method.

Authors:  M Oka; A Rekonen; J Kuikka; J Anttinen
Journal:  Scand J Rheumatol       Date:  1975       Impact factor: 3.641

2.  Osteoporosis in rheumatoid arthritis.

Authors:  A O Bjelle; B E Nilsson
Journal:  Calcif Tissue Res       Date:  1970

3.  Histomorphometric analysis of bone biopsies from the iliac crest of normal British subjects.

Authors:  S Vedi; J E Compston; A Webb; J R Tighe
Journal:  Metab Bone Dis Relat Res       Date:  1982

4.  Femoral bone mass in patients with rheumatoid arthritis and osteoarthrosis.

Authors:  D A Hancock; S Asiedu-Offei; P J Atkinson; G W Reed; V Wright
Journal:  Rheumatol Rehabil       Date:  1978-05

5.  The osteoporosis of rheumatoid arthritis.

Authors:  H Duncan; H M Frost; A R Villanueva; J W Sigler
Journal:  Arthritis Rheum       Date:  1965-10

6.  Osteoporosis of rheumatoid arthritis: influence of age, sex and corticosteroids.

Authors:  P D Saville; O Kharmosh
Journal:  Arthritis Rheum       Date:  1967-10

7.  Prevalence of decreased bone mass in rheumatoid arthritis. Relation to anti-inflammatory treatment.

Authors:  O S Als; C Christiansen; C Hellesen
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

8.  Metabolic bone disease among in-patients with rheumatoid arthritis.

Authors:  B P Wordsworth; S Vipond; C G Woods; A G Mowat
Journal:  Br J Rheumatol       Date:  1984-11

9.  Incidence of metabolic bone disease in rheumatoid arthritis and osteoarthritis.

Authors:  K C Ng; P A Revell; M Beer; B J Boucher; R D Cohen; H L Currey
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

10.  Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment.

Authors:  D M Reid; N S Kennedy; M A Smith; P Tothill; G Nuki
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-31
View more
  8 in total

Review 1.  Nitric oxide and bone.

Authors:  R J van't Hof; S H Ralston
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

2.  Dynamic exercises in patients with rheumatoid arthritis.

Authors:  A P Anandarajah; E M Schwarz
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

Review 3.  [Systemic manifestations of rheumatoid arthritis].

Authors:  M Uffmann
Journal:  Radiologe       Date:  2006-05       Impact factor: 0.635

4.  Inflammatory osteolysis in diabetic neuropathic (charcot) arthropathies of the foot.

Authors:  David R Sinacore; Mary K Hastings; Kathryn L Bohnert; Faye A Fielder; Dennis T Villareal; Vilray P Blair; Jeffrey E Johnson
Journal:  Phys Ther       Date:  2008-09-18

5.  Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis.

Authors:  E M Gravallese; Y Harada; J T Wang; A H Gorn; T S Thornhill; S R Goldring
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

Review 6.  Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis.

Authors:  C B Confavreux; R D Chapurlat
Journal:  Osteoporos Int       Date:  2010-10-20       Impact factor: 4.507

Review 7.  Inflammation regulates fibroblast growth factor 23 production.

Authors:  Connor Francis; Valentin David
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

Review 8.  Interleukin-6 and rheumatic diseases.

Authors:  Peter E Lipsky
Journal:  Arthritis Res Ther       Date:  2006-07-28       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.